WUHAN: Chinese experts have revealed that the phase one and two clinical trials of the world’s first inactivated coronavirus vaccine produced antibodies in participants.
As per details, the vaccine is developed by the Wuhan Institute of Biological Products under the China National Biotec Group (CNBG) affiliated to the China National Pharmaceutical Group (Sinopharm).
The results of the clinical trial showed that the vaccination is safe and has no serious reaction, according to researchers.
They stated that after adopting different procedures and doses of vaccination, all 1,120 participants in the vaccine group produced high titers of antibodies.
All 1,120 volunteers in phase Ⅰ/Ⅱ clinical trials have successfully made #antibodies against the #COVID19 after accepting two doses of the #COVID19 vaccine made by an institute under Sinopharm CNBG in Beijing. The vaccine has proven to be effective and safe. pic.twitter.com/k9VXBTbeCh
— Global Times (@globaltimesnews) June 28, 2020